The Paramesu Biotech IPO is a book-built issue comprising a fresh issue of equity shares worth up to ₹520 crore and an offer for sale (OFS) of up to 85 lakh equity shares with a face value of ₹5 per share. The company filed its DRHP with SEBI on November 7, 2024. The price band and official dates of subscription and listing will be announced by the company later, but the shares are su... https://www.indiaipo.in/ipo-blogs/paramesu-biotech-ipo